Aurora Cannabis Inc (NYSE: ACB) Q2 2020 Earnings Conference Call February 13, 2020 Corporate Participants: Michael Singer -- Interim Chief Executive Officer and Executive
Aurora Cannabis Inc.
-(ACB)
Aurora Cannabis (ACB) reports wider Q2 loss; launches Cannabis 2.0 in Canada
For Aurora Cannabis, Inc. (NYSE: ACB), the last few months have been momentous, marked by key organizational changes including an executive reshuffle.
Earnings preview: Aurora Cannabis (ACB) likely to post a narrower loss in Q2
Aurora Cannabis Inc. (NYSE: ACB) is slated to report its second-quarter 2020 on Thursday before the market opens. The top line will
Aurora Cannabis’ stock tanks amid new corporate developments
Shares of Aurora Cannabis (NYSE: ACB) fell over 8% in morning trade on Monday as the company announced several updates from the
Cannabis stocks: Major players see a pickup amid FDA warnings
The stocks of major cannabis companies appear to be picking up after seeing a drop following FDA warnings over the safety of
Aurora Cannabis (NYSE: ACB) Q1 profit dips 90% but beats estimates
Aurora Cannabis Inc. (NYSE: ACB) reported a 154% jump in revenues for the first quarter of 2020 helped by higher cannabis production
Aurora Cannabis (ACB) earnings preview: What to look for in Q1 report
Aurora Cannabis, Inc. (NYSE: ACB) is all set to publish its first-quarter results Thursday after the closing bell. The company continues to
Aphria, Canopy Growth, Aurora Cannabis bow to pressure from vaping fatalities
Leading players in the cannabis industry were bleeding on Monday after the Centers for Disease Control and Prevention (CDC) revealed that it